IRIS
COLOMBO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.738
AS - Asia 4.373
SA - Sud America 936
EU - Europa 934
Continente sconosciuto - Info sul continente non disponibili 223
AF - Africa 102
OC - Oceania 5
Totale 11.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.557
SG - Singapore 2.608
CN - Cina 844
BR - Brasile 765
VN - Vietnam 402
IT - Italia 237
IE - Irlanda 183
FI - Finlandia 157
HK - Hong Kong 114
IN - India 81
GB - Regno Unito 72
CA - Canada 68
DE - Germania 68
AR - Argentina 62
BD - Bangladesh 60
MX - Messico 56
FR - Francia 46
IQ - Iraq 32
TR - Turchia 31
PK - Pakistan 29
ZA - Sudafrica 28
RU - Federazione Russa 24
PL - Polonia 23
SE - Svezia 23
UA - Ucraina 23
CO - Colombia 21
EC - Ecuador 21
JP - Giappone 20
NL - Olanda 20
VE - Venezuela 18
CL - Cile 17
ID - Indonesia 17
PY - Paraguay 16
AE - Emirati Arabi Uniti 15
MA - Marocco 15
KE - Kenya 13
MY - Malesia 13
UZ - Uzbekistan 13
ES - Italia 12
CR - Costa Rica 10
JO - Giordania 10
NG - Nigeria 10
PH - Filippine 10
JM - Giamaica 9
TW - Taiwan 8
AL - Albania 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
HN - Honduras 7
AZ - Azerbaigian 6
GT - Guatemala 6
OM - Oman 6
PE - Perù 6
RO - Romania 6
SA - Arabia Saudita 6
UY - Uruguay 6
ET - Etiopia 5
PR - Porto Rico 5
AT - Austria 4
AU - Australia 4
BO - Bolivia 4
CY - Cipro 4
GE - Georgia 4
IL - Israele 4
KZ - Kazakistan 4
LT - Lituania 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
TH - Thailandia 4
BE - Belgio 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GH - Ghana 2
HU - Ungheria 2
KH - Cambogia 2
NI - Nicaragua 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
Totale 11.070
Salva come PNG Salva come JPEG
Città #
Singapore 1.034
Ashburn 950
San Jose 766
The Dalles 453
Shanghai 362
Council Bluffs 264
New York 259
Boardman 204
Dallas 201
Dublin 183
Helsinki 157
Beijing 150
Los Angeles 147
Ho Chi Minh City 131
Hanoi 116
Santa Clara 110
Hong Kong 103
São Paulo 78
Milan 75
Buffalo 66
Rome 49
Seattle 44
Chandler 38
Wilmington 29
Phoenix 28
Mexico City 23
Chicago 22
Warsaw 21
Charlotte 20
Brooklyn 19
Atlanta 18
Brasília 18
Chennai 18
Johannesburg 18
London 18
Montreal 18
Rio de Janeiro 18
Toronto 18
Da Nang 17
Assago 16
Curitiba 16
Pune 16
Tokyo 16
Turin 16
Boston 15
Baghdad 12
Nairobi 12
Naples 12
Orem 11
Porto Alegre 11
San Francisco 11
Can Tho 10
Frankfurt am Main 10
Haiphong 10
Manchester 10
Quito 10
Amsterdam 9
Ankara 9
Benin City 9
Guarulhos 9
Reston 9
San Mateo 9
Stockholm 9
Tashkent 9
Buenos Aires 8
Hillsboro 8
Hải Dương 8
Moscow 8
Recife 8
San José 8
Uberlândia 8
Belo Horizonte 7
Bến Tre 7
Campo Grande 7
Dhaka 7
Figino 7
Guangzhou 7
Kuala Lumpur 7
Manaus 7
Pasadena 7
Princeton 7
Santiago 7
Amman 6
Ann Arbor 6
Caxias do Sul 6
Denver 6
Dubai 6
Kyiv 6
Lahore 6
Lauterbourg 6
Munich 6
Muscat 6
Natal 6
Osasco 6
Paris 6
Santo Domingo 6
Sorocaba 6
Baku 5
Blumenau 5
Chengdu 5
Totale 6.787
Salva come PNG Salva come JPEG
Nome #
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 134
A Propensity Score Matched Comparative Study Between Paclitaxel-Coated Balloon and Everolimus-Eluting Stents for the Treatment of Small Coronary Vessels 97
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 96
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 93
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 86
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 83
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 82
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 81
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 80
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 79
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 76
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 75
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 74
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 72
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 70
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 70
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 69
Advances in percutaneous interventional therapies: The tricuspid valve 68
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 68
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 68
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis 67
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 66
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 65
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 64
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 64
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 62
The coronary sinus reducer: clinical evidence and technical aspects 62
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 62
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry 62
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 61
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 61
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 61
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 61
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 61
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 60
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 59
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 59
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 59
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 58
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 58
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 57
Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection 56
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 56
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 56
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 56
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 56
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 55
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 55
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 55
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 55
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 55
Repeat MitraClip for early recurrent mitral regurgitation 55
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 54
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 54
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 54
Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options 54
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study 54
A Fully Percutaneous Transeptal Transcatheter Mitral Valve Replacement With a Novel Device 54
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 54
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 54
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry 53
Prognostic value of tricuspid regurgitation 53
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 53
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 53
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 52
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 52
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock 52
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 52
Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion 52
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club 52
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 52
Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: A real-world experience 52
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study 51
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions 51
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 51
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 51
Prolonged Ultrasound-Assisted Catheter-Directed Low-Dose Thrombolysis for Acute Pulmonary Embolism Unresponsive to Systemic Thrombolysis 51
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 51
New generation bioresorbable scaffold technologies: An update on novel devices and clinical results 51
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry 51
Intraarterial thrombolysis for treatment of peripheral graft thrombosis: advantage of the radial approach 50
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: Early results of the feasibility trial 50
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 50
Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry 50
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 50
Contrast-induced kidney injury: how does it affect long-term cardiac mortality? 50
Multimodality Imaging of a Very Late Thrombosis of a Sutureless Aortic Prosthesis 50
Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions 49
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 49
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals 49
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 49
The Evolution From Surgery to Percutaneous Mitral Valve Interventions The Role of the Edge-to-Edge Technique 49
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 49
Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention 49
How should i treat recurrent restenosis with underexpanded multilayered struts after repeated complex bifurcation stenting? 48
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 48
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 48
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 48
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 48
Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort 48
Totale 5.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 6 0 0 1 5 0 1 7 1
2022/2023401 9 4 8 24 22 11 2 10 48 38 207 18
2023/20241.675 106 80 386 139 128 312 77 73 25 55 133 161
2024/20252.310 70 5 7 37 53 305 159 129 464 620 253 208
2025/20266.254 913 411 275 499 214 314 1.867 226 343 421 272 499
2026/2027611 264 347 0 0 0 0 0 0 0 0 0 0
Totale 11.311